SHP-1 Regulates Antigen Cross-Presentation and Is Exploited by Leishmania to Evade Immunity

被引:14
|
作者
Khouili, Sofia C. [1 ]
Cook, Emma C. L. [2 ]
Hernandez-Garcia, Elena [2 ]
Martinez-Lopez, Maria [3 ]
Conde-Garrosa, Ruth [1 ]
Iborra, Salvador [2 ]
机构
[1] Ctr Nacl Invest Cardiovasculares Carlos III CNIC, Immunobiol Lab, Madrid 28029, Spain
[2] Univ Complutense Madrid, Sch Med, 12 Octubre Hlth Res Inst Imas12, Dept Immunol, Madrid, Spain
[3] Champalimaud Ctr Unknown, Champalimaud Res, Av Brasilia, P-1400038 Lisbon, Portugal
来源
CELL REPORTS | 2020年 / 33卷 / 09期
关键词
antigen cross-presentation; Clec4e; dendritic cells; immune evasion; Leishmania; Mincle; Ptpn6; SHP-1; sialic acid; vaccines;
D O I
10.1016/j.celrep.2020.108468
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Intracellular pathogens have evolved strategies to evade detection by cytotoxic CD8(+) T lymphocytes (CTLs). Here, we ask whether Leishmania parasites trigger the SHP-1-FcRg chain inhibitory axis to dampen antigen cross-presentation in dendritic cells expressing the C-type lectin receptor Mincle. We find increased cross-priming of CTLs in Leishmania-infected mice deficient for Mincle or with a selective loss of SHP-1 in CD11c(+) cells. The latter also shows improved cross-presentation of cell-associated viral antigens. CTL activation in vitro reveals increased MHC class I-peptide complex expression in Mincle- or SHP-1-deficient CD11c(+) cells. Neuraminidase treatment also boosts cross-presentation, suggesting that Leishmania triggers SHP1-associated sialic-acid-binding receptors. Mechanistically, enhanced antigen processing correlates with reduced endosomal acidification in the absence of SHP-1. Finally, we demonstrate that SHP-1 inhibition improves CD11c(+) cell-based vaccination against the parasite. Thus, SHP-1-mediated impairment of cross-presentation can be exploited by pathogens to evade CTLs, and SHP-1 inhibition improves CTL responses during vaccination.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Antigen Cross-Presentation by Macrophages
    Muntjewerff, Elke M.
    Meesters, Luca D.
    van den Bogaart, Geert
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [2] Leishmania Evades Host Immunity by Inhibiting Antigen Cross-Presentation through Direct Cleavage of the SNARE VAMP8
    Matheoud, Diana
    Moradin, Neda
    Bellemare-Pelletier, Angelique
    Shio, Marina Tiemi
    Hong, Wan Jin
    Olivier, Martin
    Gagnon, Etienne
    Desjardins, Michel
    Descoteaux, Albert
    [J]. CELL HOST & MICROBE, 2013, 14 (01) : 15 - 25
  • [3] On the role of antigen stability in antigen cross-presentation
    Knittel, D.
    Savatier, A.
    Leonetti, M.
    [J]. IMMUNOLOGY, 2012, 137 : 767 - 767
  • [4] Antigen presentation - A new route to cross-presentation
    Bell, E
    [J]. NATURE REVIEWS IMMUNOLOGY, 2005, 5 (04) : 268 - 268
  • [5] Mechanism of cross-presentation of microencapsulated antigen
    Park, Kinam
    [J]. JOURNAL OF CONTROLLED RELEASE, 2011, 151 (03) : 219 - 219
  • [6] VAMP3 as a negative regulator of Leishmania amazonensis infection and antigen cross-presentation
    Seguin, Olivier
    Descoteaux, Albert
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [7] Current Concepts of Antigen Cross-Presentation
    Embgenbroich, Maria
    Burgdorf, Sven
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [8] Antigen cross-presentation of immune complexes
    Platzer, Barbara
    Stout, Madeleine
    Fiebiger, Edda
    [J]. FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [9] The Role of Antigen Cross-presentation From Leukemia Blasts on Immunity to the Leukemia-associated Antigen PR1
    Alatrash, Gheath
    Ono, Yoko
    Sergeeva, Anna
    Sukhumalchandra, Pariya
    Zhang, Mao
    St John, Lisa S.
    Yang, Tian-Hui
    Ruisaard, Kathryn
    Armistead, Paul M.
    Mittendorf, Elizabeth A.
    He, Hong
    Qiao, Na
    Rodriguez-Cruz, Tania
    Liang, Shoudan
    Clise-Dwyer, Karen
    Wieder, Eric D.
    Lizee, Gregory
    Lu, Sijie
    Molldrem, Jeffrey J.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2012, 35 (04) : 309 - 320
  • [10] Spatial separation of cross-presentation and endogenous antigen presentation
    Burgdorf, S.
    Schoelz, C.
    Kautz, A.
    Tampe, R.
    Kurts, C.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 36 - 36